0.4700GBP0.00%Mkt Cap: 2.73M $P/E: —1d ago
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Swit…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap2.73M $
Enterprise Value1.50M $
Revenue (TTM)1.29M $
Gross Profit-658.08K $
Net Income (TTM)-532.61K $
Revenue/Share0.0038 USD
Last Price0.4700 GBP
Fiscal Year EndJun 2025
MR QuarterDec 2025
Employees10
CountryGB
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.01
PEG—
EV/EBITDA-2.23
EV/Revenue1.16
P/S2.11
P/B4.69
EPS (TTM)0.00
EPS (Forward)-0.34
52W Range
0.253040% of range0.8000
52W High0.8000 GBP
52W Low0.2530 GBP
Profitability
Gross Margin-50.89%
Oper. Margin-61.93%
EBITDA Margin-51.91%
Profit Margin-52.97%
ROE-59.99%
ROA-46.55%
Growth
Revenue Growth49.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-700.49K $
CapEx (TTM)5.05K $
FCF Margin-31.45%
FCF Yield-14.89%
Net Debt-329.63K $
Net Debt/EBITDA0.49
Balance Sheet
Debt/Equity—
Current Ratio3.30
Quick Ratio3.30
Book Value/Sh0.0010 GBP
Cash/Share0.0010 GBP
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBP
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:100
Split DateDec 19, 2016
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.453.21M
Float209.93M
Insiders23.64%
Institutions2.30%
Technical
SMA 500.4887 (-3.8%)
SMA 2000.4552 (+3.2%)
Beta1.04
S&P 52W Chg18.16%
Avg Vol (30d)3.52M
Avg Vol (10d)2.62M
Technical Indicators
RSI (14)46.6
MACD-0.0118
MACD Signal-0.0137
MACD Hist.+0.0020
BB Upper0.5030 GBP
BB Middle0.4708 GBP
BB Lower0.4385 GBP
BB Width13.70%
ATR (14)0.0365 GBP
Vol Ratio (20d)0.02x